Source: The Pharma Letter

Silvergate: FDA approves Silvergate's pediatric lisinopril Qbrelis

The US Food and Drug Administration approved Qbrelis (lisinopril) oral solution from Silvergate Pharmaceuticals,...

Read full article »
Silvergate's Competitors | Silvergate's News | Silvergate's Financials
Stay up-to-date with the latest news on Silvergate Pharmaceuticals
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Neal I. Muni's photo - President & CEO of Silvergate Pharmaceuticals

President & CEO

Neal I. Muni

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Silvergate Pharmaceuticals